Reach Us +443308085114
Editor - Rodney J Y Ho | University of Washington | 2089
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Rodney J Y Ho

Rodney J Y Ho
Rodney J Y Ho
Professor of Pharmaceutics
University of Washington
Tel. 206-543-3796
Fax 206-221-2689
University of Washington


Dr. Ho is the Milo Gibaldi Endowed Professor of Pharmaceutics and Director of the DNA Sequencing and Gene Analysis Center at University of Washington, Seattle. He also holds appointments at Clinical Pharmacology Fred Hutchinson Cancer Research Center, the Center for AIDS and STD Research the Center for Human Development and Disability the Center for Ecogenetics at University of Washington and the Washington National Primate Research Center. He served as an Associate Dean for Research and New Initiatives from 2006-09 and is an associate editor for J Pharmaceutical Sciences.

Research Interest

His research interests are in elucidating mechanisms of protein and drug disposition, and genetic basis of inter-individual variation in therapeutic responses. Fundamental understanding of these physio- and biological processes form the basis of the focus of Dr. Hos research in developing drug delivery strategies for treatment of AIDS and cancers using drugs, DNA, proteins and antigens. All the research programs in his laboratory have the common goal of delivering therapeutic compounds of interest to select target tissues or cells to enhance drug safety and/or efficacy.